Physical Fitness in DS: A Comparison of Cuevas Medak and Rebound Exercises
Effects of Cuevas Medak Exercises Vs Rebound Exercises on Physical Fitness in Children With Down Syndrome
Riphah International University
22 participants
Oct 22, 2025
INTERVENTIONAL
Conditions
Summary
This randomized clinical trial investigates the comparative effects of Cuevas Medak Exercises Vs Rebound Exercises on physical fitness in DS. The.current study will be single blinded randomized clinical design in which nonprobability convenience sampling technique will be used. Inclusion criteria will be Down Syndrome. both genders will be included. The study involves 22 DS aged 3-8, will be assigned using lottery method, the participants will be randomly divided into two groups. One group will be given Cuevas Medek Exercises and the other with Rebound exercises. SAMU-Disability Fitness (DISFIT) battery will be used to assess the Physical Fitness in Down syndrome. Both groups will be given three treatment session per week for 12 weeks and total time for each session will be 30-45 minutes. . Data will be analyzed through SPSS version 26.0
Eligibility
Inclusion Criteria4
- Children with Down syndrome
- Age 3-8 years Both genders
- Children who were able to understand the commands given to them.
- They were able to stand and walk independently.
Exclusion Criteria10
- Patients with medical conditions that would severely limit their participation in the study
- Hearing loss
- Contracture
- Musculoskeletal disorders,
- Atlanto-axial instability
- Cardiac anomalies
- Thyroid abnormality
- Seizures
- Uncorrected vision problems
- Orthopedic surgery or spasticity-reduction intervention
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Group A 11 children of DS will be given Cuevas Medak Exercises for 12 weeks and total time for each session will be 30-45 min. Group B 11 children of DS will be given Rebound Exercises for 15 min though this can be broken into multiple 3-5 min
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07248449